Genetic Silencing of Striatal CaV1.3 Calcium Channels as a Potent Antidyskinetic Therapy for PD
|Effective start/end date||7/1/21 → 6/30/23|
- HHS: National Institutes of Health (NIH): $235,965.00
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.